First thyroid eye disease drug inches closer to approval

An FDA advisory committee unanimously backed teprotumumab as the first nonsurgical treatment for thyroid eye disease, according to a press release by Horizon Therapeutics.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553